NO20006442L - Fremgangsmate for a danne liposomer - Google Patents

Fremgangsmate for a danne liposomer

Info

Publication number
NO20006442L
NO20006442L NO20006442A NO20006442A NO20006442L NO 20006442 L NO20006442 L NO 20006442L NO 20006442 A NO20006442 A NO 20006442A NO 20006442 A NO20006442 A NO 20006442A NO 20006442 L NO20006442 L NO 20006442L
Authority
NO
Norway
Prior art keywords
liposomes
compositions
forming liposomes
regent
pharmaceuticals
Prior art date
Application number
NO20006442A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006442D0 (no
Inventor
Gregory Gregoriadis
Brahim Zadi
Pramukh Nalaka Jayasekera
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Publication of NO20006442D0 publication Critical patent/NO20006442D0/no
Publication of NO20006442L publication Critical patent/NO20006442L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20006442A 1998-06-18 2000-12-15 Fremgangsmate for a danne liposomer NO20006442L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9813100.6A GB9813100D0 (en) 1998-06-18 1998-06-18 Method of forming liposomes
PCT/GB1999/001911 WO1999065465A1 (en) 1998-06-18 1999-06-16 Method of forming liposomes

Publications (2)

Publication Number Publication Date
NO20006442D0 NO20006442D0 (no) 2000-12-15
NO20006442L true NO20006442L (no) 2001-02-15

Family

ID=10833946

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006442A NO20006442L (no) 1998-06-18 2000-12-15 Fremgangsmate for a danne liposomer

Country Status (15)

Country Link
US (1) US9675554B1 (enExample)
EP (1) EP1087754B1 (enExample)
JP (1) JP4567882B2 (enExample)
KR (1) KR100658956B1 (enExample)
CN (1) CN1312707A (enExample)
AT (1) ATE287258T1 (enExample)
AU (1) AU749499B2 (enExample)
CA (1) CA2335183A1 (enExample)
DE (1) DE69923315T2 (enExample)
GB (2) GB9813100D0 (enExample)
NO (1) NO20006442L (enExample)
NZ (1) NZ508960A (enExample)
RU (1) RU2216315C2 (enExample)
WO (1) WO1999065465A1 (enExample)
ZA (1) ZA200007507B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE341310T1 (de) * 2000-02-04 2006-10-15 Lipoxen Technologies Ltd Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
WO2002038128A1 (fr) * 2000-11-10 2002-05-16 Japan Science And Technology Corporation Procede de preparation d'une dispersion de microsome
AU3652602A (en) * 2000-11-15 2002-05-27 Us Gov Health & Human Serv Sol-fusin: use of gp64-6his to catalyze membrane fusion
BRPI0105509B8 (pt) 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
US7285289B2 (en) * 2002-04-12 2007-10-23 Nagy Jon O Nanoparticle vaccines
KR100482355B1 (ko) * 2002-05-02 2005-04-14 주식회사 알로에마임 디팔미토일하이드록시프롤린과 소이이소플라본을 함유한리포좀 또는 나노에멀젼 및 이를 함유한 화장료 조성물 및그 제조방법
SI2108362T1 (sl) * 2002-06-26 2013-08-30 Medigene Ag Kationski nosilni sistem, ki vsebuje taksan
ES2331791T5 (es) 2002-06-26 2016-01-21 Medigene Ag Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo
US20050175683A1 (en) * 2003-10-24 2005-08-11 Yuanpeng Zhang Preparation of lipid particles
KR101462825B1 (ko) 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
ATE454884T1 (de) * 2004-10-18 2010-01-15 Polymun Scient Immunbio Forsch Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
JP2009510032A (ja) 2005-09-30 2009-03-12 リポクセン テクノロジーズ リミテッド 多糖抗原及びタンパク質アジュバントを含む多価リポソームワクチン組成物
RU2300369C1 (ru) * 2005-12-27 2007-06-10 Наталья Ивановна Ларионова Способ получения полиэлектролитных микрочастиц, содержащих инкапсулируемое вещество, чувствительных к изменению состава окружающей среды
EP2492278A1 (en) 2006-09-18 2012-08-29 Compugen Ltd. Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy
CA2693651A1 (en) 2007-07-12 2009-01-15 Ronen Shemesh Bioactive peptides and method of using same
JP5362998B2 (ja) * 2008-01-10 2013-12-11 第一ファインケミカル株式会社 乾燥リポソーム製剤
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
WO2010041255A2 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
EP2184054A1 (en) 2008-11-08 2010-05-12 Lipoxen Technologies Limited Small Interfering RNA Delivery
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
RU2409668C1 (ru) * 2009-09-02 2011-01-20 Александр Анатольевич Ярославов Способ получения иммобилизованных бислойных везикул
KR20110068831A (ko) 2009-12-16 2011-06-22 재단법인 전라남도생물산업진흥재단 리포좀 조성물, 그 제조방법, 및 폐렴 백신으로서의 그 용도
FR2958851B1 (fr) * 2010-04-16 2012-06-29 Xeda International Nouvelles formulations d'ingredient(s) actif(s) d'origine vegetale ou leurs analogues synthetiques ou d'extrait(s) d'origine vegetale les contenant, et de lecithine
BR112013017267B1 (pt) 2011-01-04 2021-06-22 Archivel Farma, Sl Formulação de lipossomas, suspensão e composição farmacêutica
PT2768484T (pt) 2011-10-21 2019-10-28 Jazz Pharmaceuticals Res Llc Lipossomas liofilizados
IN2014MN01594A (enExample) 2012-01-12 2015-05-08 Archivel Farma Sl
EA023079B1 (ru) * 2012-12-24 2016-04-29 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы иринотекана (варианты)
JP6866060B2 (ja) * 2014-10-27 2021-04-28 花王株式会社 精製茶抽出物の製造方法
KR101739208B1 (ko) * 2014-12-30 2017-05-25 (주)셀트리온 표피성장인자와 리포좀의 하이브리드형 다중층 나노구조체 및 그 제조방법
WO2016191700A1 (en) * 2015-05-27 2016-12-01 Nuvox Pharma Llc Treatment of acute complications of sickle cell disease
WO2017049132A1 (en) * 2015-09-18 2017-03-23 DNARx Systems and methods for nucleic acid expression in vivo
ES3036518T3 (en) 2015-10-16 2025-09-19 Ipsen Biopharm Ltd Stabilizing camptothecin pharmaceutical compositions
EP3600428A4 (en) 2017-03-23 2020-08-26 Dnarx SYSTEMS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS IN VIVO
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
RU2697802C1 (ru) * 2018-08-23 2019-08-20 Федеральное Государственное Бюджетное Учреждение Науки Институт Биохимической Физики Им. Н.М. Эмануэля Российской Академии Наук (Ибхф Ран) Способ получения магнитных липосом

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
EP0208764A4 (en) * 1985-01-11 1987-10-08 Univ California METHOD FOR PRESERVING LIPOSOMES.
CA1256372A (en) * 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US5094785A (en) * 1986-12-10 1992-03-10 Ciba Corning Diagnostics Corp. Process for stabilizing liposomes
AU612631B2 (en) * 1987-02-24 1991-07-18 Vestar, Inc. Dehydrating vesicule preparations for long-term storage
US5089181A (en) * 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
JP2780755B2 (ja) * 1987-05-22 1998-07-30 ザ リポソーム カンパニー，インコーポレイテッド プロスタグランジン‐脂質製剤
DE68916439T2 (de) * 1988-10-05 1994-10-20 Vestar Inc Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
RU2014071C1 (ru) * 1991-03-26 1994-06-15 Научно-производственный центр медицинской биотехнологии Способ получения липосом, содержащих водорастворимые низкомолекулярные соединения
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
WO1993020802A1 (en) * 1992-04-09 1993-10-28 Northwestern University Acoustically reflective liposomes and methods to make and use the same
DK0678017T3 (da) * 1993-11-05 1998-10-19 Amgen Inc Liposomfremstilling og materialeindkapslingsfremgangsmåde
EP0914094A4 (en) * 1996-03-28 2000-03-01 Univ Illinois MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS
CA2202103C (en) * 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
JP3693209B2 (ja) * 1996-04-11 2005-09-07 三菱化学株式会社 閉鎖小胞の製造方法
RU2123328C1 (ru) * 1996-04-19 1998-12-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Липосомальное противовирусное лекарственное средство для перорального применения
NZ332666A (en) * 1996-05-08 2000-05-26 Nika Health Products Ltd Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy

Also Published As

Publication number Publication date
RU2216315C2 (ru) 2003-11-20
NZ508960A (en) 2002-11-26
CN1312707A (zh) 2001-09-12
NO20006442D0 (no) 2000-12-15
GB2354166B (en) 2003-09-10
ATE287258T1 (de) 2005-02-15
GB9813100D0 (en) 1998-08-19
KR20010053006A (ko) 2001-06-25
US9675554B1 (en) 2017-06-13
JP2003513003A (ja) 2003-04-08
EP1087754B1 (en) 2005-01-19
KR100658956B1 (ko) 2006-12-21
AU749499B2 (en) 2002-06-27
GB0030767D0 (en) 2001-01-31
EP1087754A1 (en) 2001-04-04
DE69923315D1 (de) 2005-02-24
ZA200007507B (en) 2002-03-14
GB2354166A (en) 2001-03-21
WO1999065465A1 (en) 1999-12-23
CA2335183A1 (en) 1999-12-23
DE69923315T2 (de) 2006-04-06
AU4518099A (en) 2000-01-05
JP4567882B2 (ja) 2010-10-20

Similar Documents

Publication Publication Date Title
NO20006442D0 (no) Fremgangsmåte for å danne liposomer
WO2004054499A3 (en) Platinum aggregates and process for producing the same
DE3787866D1 (de) Alkalische Cellulasen und Mikroorganismen zu deren Herstellung.
PL322723A1 (en) Substituted 1-phenypyrazole-3-carboxyamides as active substances in respect to neurotensin rceptors, their production and pharmaceutic compositions containing them
CA2072420A1 (en) Storage of materials
ES2165508T3 (es) Material polimerico, procedimiento para su fabricacion y su uso.
ZA863346B (en) Novel surface-active composition,the process for the production thereof and the uses thereof
PL324328A1 (en) Novel nucleic acid construct, method of obtaining same, application thereof, method of manufacturing a pharmaceutic agent, method of producing cells, method of producing protein and pharmaceutic agent as such
NZ319557A (en) Construction framework intercrossing beams
GR3015110T3 (en) Urea production process with high energy efficiency.
GB2294045B (en) Novel sulfonate, process for producing the same, and bleach composition comprising the same
AU583196B2 (en) Detergent composition and process for its production
CA2318868A1 (en) Chemical agent for improving the engineering properties of soil
AU1802100A (en) Floating pesticide compositions for paddy fields, method for the utilization thereof and process for producing the same
IT8919477A0 (it) Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
WO2003051927A3 (en) Production of f(ab')2 fragments in mammalian cells
CA2261948A1 (en) A process and composition for detergents
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
NO20005424D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
WO2001009065A3 (de) Nitrierung in einem statischen mikromischer
DE3788389D1 (de) Cervinomycinabkömmlinge als antibiotika und deren herstellungsverfahren.
RU2000132870A (ru) Керамическая масса для изготовления изделий стеновой керамики
AU4261599A (en) Amphotropic retrovirus packaging cell line, process for its production and use thereof
FI930395A0 (fi) Foerfarande foer framstaellning av bakverk
EP0385960A3 (en) Mineral mix and procedure for manufacturing same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application